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Two studies shed light onOct4 behavior under different conditions to illuminate how cells maintain the plurip-
otent state and exit from it.The complex interplay of transcription
factors is critical to controlling cell fate
decisions. In this issue, two studies of
stem cell behavior highlight contrasting
approaches to understanding cell type
stability and fate changes. Both center
on the key transcription factor, Oct4.
Ding et al. (2015) take a systematic,
genome-wide approach to understand-
ing the genomic control of the steady
state epiblast stem cells (EpiSCs). They
characterize the layers of regulation plu-
riopotent cells place on Oct4 expression.
Meanwhile, Sokolik et al. (2015) suggest
that commitment to a neurectoderm cell
fate is critically dependent on a two-state
switch between the activity of Oct4
and a second transcription factor Brn2.
Their work demonstrates how competi-
tion between transcription factors exe-
cutes the switching behavior required to
exit a stable cell fate. Overall, both
studies illustrate that characterizing the
dynamics of transcriptional regulation
will be essential to mechanistically un-
derstand these and other developmental
systems (Figure 1).
Genome-wide screens, like that con-
ducted by Ding et al., typically end with
the characterization of a few specific
knockdowns and the description of a pu-
tative protein complex, already a substan-
tial amount of work. However, Ding et al.
step things up: not only do they charac-
terize the knockdowns genome-wide,
they illustrate pair-wise interactions be-
tween genes and move beyond gene
expression to define ‘‘protein-level de-
pendency’’ within a phenotypically impor-
tant subset of genes. Protein-level depen-
dency uses GFP reporters to measure
how knockdown of one factor affects the
protein levels of all the other members of
the analyzed gene set.100 Cell Systems 1, August 26, 2015 ª2015 ENaturally, these later stages of analysis
lose the genome-wide power of the
shRNA knockdown screen as only a
restricted set of genes can feasibly be
analyzed, but they provide critical infor-
mation about how manipulation of each
factor affects others, both transcription-
ally and post-transcriptionally.
Ding et al. characterize the regulatory
network underlying the EpiSC cell state,
a cell type thought to be related to the
late embryonic epiblast and primitive
streak stage of gastrulating embryos (Ko-
jima et al., 2014). These observations
culminate in the startling observation
that, even in unstimulated EpiSCs, Oct4,
despite being functionally required
(DeVeale et al., 2013), is under significant
transcriptional repression. This contrasts
with embryonic stem cells (ESCs), which
are derived from the earlier inner cell
mass of the pre-implantation embryo
and see no such wide-scale repression
of Oct4.
The work by Ding et al. provides a
tantalizing hint about a crucial point in
development, the exit from pluripotency
in the gastrulating embryo, a critical but
poorly understood process at themolecu-
lar level. Their work suggests that the
active suppression of Oct4 is a require-
ment for epiblast-like cells to leave the
gastrulating primitive streak and so
commit to a differentiated cell type. This
implies that the EpiSCs are a barely stable
cell type, precariously balanced on the
exit from pluripotency, while the develop-
mentally earlier ESCs are more robust to
perturbation. This hypothesis rests on
two caveats. First, the exact relationship
of thewell-characterized ESCs to the cells
of the pluripotent inner cell mass remains
unclear (Boroviak et al., 2014), much less
the closest in vivo cell type for the lesslsevier Inc.well-characterized EpiSCs. This is an
important consideration because the abil-
ity to indefinitely self-renew and maintain
pluripotency is not a feature of in vivo
epiblast cells which only exist transiently
in the embryo. Instead, the default state
is to exit pluripotency and rapidly commit
to a differentiated cell type. The long term
in vitro culture of embryonic-like cells re-
mains a technical artifact, albeit one that
is incredibly useful.
In a related study also published in this
issue, Sokolik et al. explore the mecha-
nisms by which ESCs maintain a stable
state when confronted with a differentia-
tion-inducing transcription factors. Spe-
cifically, they study the ectopic expres-
sion of a light-inducible Brn2 (also called
Pou3f2), a transcription factor known to
drive mESCs to neurectoderm (Lodato
et al., 2013). This elaborate experimental
set up allows Sokolik et al. to modulate
the level of Brn2 expression across time,
so the authors can tease apart the precise
thresholds required for exit from pluripo-
tency, as measured by fluorescence of a
Nanog-GFP reporter. Their mathematical
models indicate that Oct4 and Brn2 act
as a ‘‘two-state switch’’ to activate or
deactivate Nanog expression, subject to
two critical thresholds of Brn2 activity—
magnitude and duration. When both
thresholds are crossed, cells decrease
Nanog levels and exit pluripotency.
Mechanistically, Sokolik et al. charac-
terize the switch-like exit from pluripo-
tency as a (relatively) simple competition
between Oct4 and Brn2 for binding to
Sox2: Sox2’s recruitment into a Sox2-
Brn2 complex effectively reducing Nanog
transcription by depleting the Sox2-Oct4
complex from the Nanog promoter. How-
ever, recent work indicates that Brn2,
along with Oct6 and Brn1, has additional
Figure 1. Decision Making at the Exit of Pluripotency
Embryonic stem cells can interconvert to EpiSCs and can terminally differentiate to neurectoderm. Ding
et al. describe the role of TOX4 and the Paf1C complex in maintaining OCT4 and describe the curious
observation that in EpiSCs OCT4 is under tremendous negative repression, despite being essential for
the EpiSC state. Sokolik et al. describes how the interplay of OCT4, SOX2, and BRN2 establish a ‘‘two-
state switch’’ to control noise inputs in determining the exit from pluripotency and the entrance to a
neurectoderm cell fate.
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late transcription by predominantly form-
ing homodimers on palindromic octamer
motifs (specifically ‘‘more palindromic oc-
tamer recognition elements’’), cis ele-
ments associated with neurectoderm
lineage genes (Mistri et al., 2015). When
taken in this light, the two-state switch
described by Sokolik et al. reflects larger
biological processes that build on, or
augment, Oct4/Brn2 competition for
binding to Sox2. This feature is not a gen-
erality for all differentiation-inducing tran-
scription factors as the authors show a
gradient rather than a two-state switch
induced by MyoD. Perhaps Brn2 acts asa pioneering factor to open up chromatin
in regulatory regions of the neurectoderm
lineage (Lodato et al., 2013), exposing
new cis elements for Sox2 to bind. Such
new sites could act as a Sox2 sink
reducing the availability of Sox2 to
interact with Oct4 and the Nanog
promoter.
The informative experimental data of
Sokolik et al. is a fruitful place to begin
dissecting the molecular mechanisms of
cell-fate decision making in mESCs.
Their proposed computational model is
purposefully coarse grained—additional
layers of regulation likely contribute
to making this cell-fate decision. ForCell Systems 1example, Sokolik et al. measure Nanog
at the protein level (i.e. not solely a tran-
scriptional read out), thus the complete
characterization of Nanog regulation likely
also needs to invoke post-transcriptional
controls, for instance microRNAs associ-
ating with Nanog mRNA (Tay et al.,
2008). Independent of these mechanistic
considerations, Sokolik et al. provide an
important experimental and conceptual
model for how cells deal with stochastic
inputs to exit (or not) from pluripotency.
It will be extremely valuable to extend
this experimental technique to other
transcription factors and other cell fate
commitment systems.
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